NRGN is a postsynaptic protein involved in synaptic signaling and remodeling (see review [17]), and in previous studies, NRGN levels correlated with t-tau and p-tau levels [8, 18–22] and were increased in (early) AD relative to controls [20, 21, 23]. The gene discussed is MAPT; the disease is Alzheimer disease.